Breaking News Instant updates and real-time market news.

AMTD

TD Ameritrade

$50.29

1.04 (2.11%)

, BAC

Bank of America

$26.59

0.4 (1.53%)

10:25
10/25/18
10/25
10:25
10/25/18
10:25

SEC to hold a roundtable

Roundtable on market data and market access which will focus on assessing current market data products, market access services, and their associated fees, and assessing the elements, governance and funding of core data infrastructure will be held at the SEC Washington, D.C. offices on October 25-26 at 10:30 am. Webcast Link

AMTD

TD Ameritrade

$50.29

1.04 (2.11%)

BAC

Bank of America

$26.59

0.4 (1.53%)

CBOE

Cboe Global Markets

$105.98

0.03 (0.03%)

ICE

IntercontinentalExchange

$74.27

0.43 (0.58%)

NDAQ

Nasdaq

$81.43

-0.13 (-0.16%)

SCHW

Charles Schwab

$43.05

0.48 (1.13%)

TROW

T. Rowe Price

$94.79

1.02 (1.09%)

VIRT

Virtu Financial

$22.73

0.34 (1.52%)

  • 25

    Oct

  • 26

    Oct

  • 31

    Oct

  • 02

    Nov

AMTD TD Ameritrade
$50.29

1.04 (2.11%)

09/19/18
JEFF
09/19/18
UPGRADE
Target $65
JEFF
Buy
Jefferies upgrades E-Trade to Buy on valuation, possible takeout upside
Jefferies analyst Daniel Fannon upgraded E-Trade (ETFC) to Buy from Hold with an unchanged price target of $65. The stock's current valuation is attractive for the core business while the financial and strategic benefits as a takeout candidate remain intact, Fannon tells investors in a research note. In a takeout scenario, Fannon thinks E-Trade could be worth as much as low $70s per share. He views TD Ameritrade (AMTD) and Charles Schwab as the most likely buyers given the expense overlaps. The analyst believes increasing competition across the Discount Brokers industry will continue to favor the firms with greater scale and revenue diversity. His favorite ideas in the group are E-Trade and Charles Schwab.
09/25/18
WOLF
09/25/18
INITIATION
Target $59
WOLF
Underperform
TD Ameritrade initiated with an Underperform at Wolfe Research
Wolfe Research analyst Steven Chubak initiated TD Ameritrade with an Underperform and $59 price target.
10/04/18
DBAB
10/04/18
NO CHANGE
DBAB
TD Ameritrade, E-Trade oversold into Q3 reports, says Deutsche Bank
Deutsche Bank analyst Brian Bedell sees shares of both TD Ameritrade (AMTD) and E-Trade (ETFC) as oversold heading into the Q3 reporting season. The setup is looking even better for e-brokers into earnings, Bedell tells investors in a research note. With e-broker stocks down a median 9% over the past month, the analyst now "heavily" favors the group within his coverage this earnings season, especially TD Ameritrade and E-Trade. He believes the market is no longer incorporating a meaningful chance of a merger scenario between the two companies. The analyst thinks both stocks can rally on "pure fundamentals."
10/19/18
SBSH
10/19/18
NO CHANGE
SBSH
E-Trade news removes bull case for Ameritrade, Schwab, says Citi
E-Trade (ETFC) last night announced new five-year financial targets and that it will pursue an independent course given higher internal estimates of intrinsic value versus a potential sale, Citi analyst William Katz tells investors in a research note. While the sector has recently sold off, the absence of a sizeable transaction "further removes a bull case thesis" for shares of both TD Ameritrade (AMTD) and Charles Schwab (SCHW), says Katz. Further, he believes the "inaction" also likely leaves open the group to more online pricing pressures and "keeps alive commodization risks." He does not rate E-Trade, has a Neutral rating on Ameritrade and Sell rating on Schwab.
BAC Bank of America
$26.59

0.4 (1.53%)

09/25/18
WOLF
09/25/18
INITIATION
Target $40
WOLF
Outperform
Bank of America initiated with an Outperform at Wolfe Research
Wolfe Research analyst Steven Chubak initiated Bank of America with an Outperform and $40 price target.
09/19/18
OPCO
09/19/18
NO CHANGE
OPCO
Outperform
U.S. banks 'in very good shape,' says Oppenheimer, favorites include BofA, Citi
Oppenheimer analyst Chris Kotowski tells investors in a research note that the U.S. banking group is on solid footing with balance sheets less risky than at any time over the last 33 years the firm covered the group and says his favorite bank stocks are Outperform-rated Bank of America (BAC), Citi (C), CIT (CIT) and Goldman Sachs (GS). However, Kotowski notes that banks are trading at an average relative P/E of just ~66% relative to the S&P 500 and returning to a historical avg valuation of 73%-80% range would imply over a thousand basis points of outperformance by the group. In his view, the U.S. banks are, on the whole, in "very good" shape.
07/17/18
BARD
07/17/18
NO CHANGE
Target $30
BARD
Neutral
Baird would be buyers of Bank of America on weakness
Baird analyst David George said he would remain a buyer of Bank of America shares on any weakness, stating that its operating leverage was impressive in Q2 and should continue along with solid execution. George maintained his Neutral rating and $30 price target on Bank of America shares.
07/09/18
GSCO
07/09/18
NO CHANGE
GSCO
Bank of America, Morgan Stanley top ideas into Q2 earnings season, says Goldman Sachs
Goldman Sachs analyst Richard Ramsden expects Bank of America (BAC) and Morgan Stanley (MS) to beat consensus estimates in Q2. The analyst argues that both appear best positioned, while he sees risk for U.S. Bancorp (USB) and JPMorgan (JPM). Ramsden highlights Bank of America given the material valuation dislocation that looks to support the stock over time. Additionally, the analyst expects an expense and NII beat for Morgan Stanley.
CBOE Cboe Global Markets
$105.98

0.03 (0.03%)

07/09/18
COMP
07/09/18
INITIATION
Target $115
COMP
Buy
Cboe Global Markets initiated with a Buy at Compass Point
Compass Point initiated Cboe Global Markets with a Buy and $115 price target.
08/20/18
RAJA
08/20/18
UPGRADE
RAJA
Outperform
Cboe Global Markets upgraded to Outperform from Market Perform at Raymond James
09/05/18
RSBL
09/05/18
INITIATION
Target $115
RSBL
Buy
Cboe Global Markets initiated with a Buy at Rosenblatt
Rosenblatt analyst Ken Hill initiated Cboe Global Markets with a Buy and $115 price target saying to own shares for a rebound in volatility and index trading activity. Hill said the backdrop for increased volumes looks more supportive and sees potential for Cboe shares to outperform as results recover and sentiment improves.
09/07/18
WELS
09/07/18
NO CHANGE
Target $115
WELS
Outperform
Cboe risk/reward attractive heading into fall, says Wells Fargo
Wells Fargo analyst Christopher Harris believes the VIX complex volumes bottomed in August, creating and attractive risk/reward for shares of Cboe Global Markets (CBOE) heading into the fall. Supporting data include steadily rising open interest trends, recent improvement in volume trends and better VIX exchange-traded product flows, Harris tells investors in a research note. In addition, Cboe's relative valuation versus CME Group (CME) "has rarely been this low," the analyst adds. He keeps an Outperform rating on Cboe Global Markets with a $115 price target.
ICE IntercontinentalExchange
$74.27

0.43 (0.58%)

06/22/18
COMP
06/22/18
INITIATION
Target $85
COMP
Buy
IntercontinentalExchange initiated with a Buy at Compass Point
Compass Point initiated IntercontinentalExchange with a Buy and $85 price target.
07/09/18
WELS
07/09/18
NO CHANGE
Target $80
WELS
Market Perform
IntercontinentalExchange price target raised to $80 from $74 at Wells Fargo
Wells Fargo analyst Christopher Harris raised his price target for IntercontinentalExchange to $80 from $74 following the release of June and Q2 volume and rate per contract data. The analyst reiterates a Market Perform rating on the shares.
09/05/18
RSBL
09/05/18
INITIATION
Target $88
RSBL
Buy
IntercontinentalExchange initiated with a Buy at Rosenblatt
Rosenblatt analyst Ken Hill initiated IntercontinentalExchange with a Buy and $88 price target saying its his "favorite long-term investment" in the sector. Hill expects the data segment will see mid-to high single-digit growth and said the transaction business will be a tailwind, fixed income initiatives look promising, and capital return potential looks solid. The analyst believes expectations have been reset following sluggish Data results the first part of the year and expects a strong back-half to build.
10/12/18
JPMS
10/12/18
NO CHANGE
Target $91
JPMS
Overweight
IntercontinentalExchange price target raised to $91 from $79 at JPMorgan
JPMorgan analyst Kenneth Worthington raised his price target for IntercontinentalExchange to $91 saying he sees the outlook for the company's data revenue growth and futures trading improving in 2019. With better data growth, ICE's valuation could see some upside, which combined with higher earnings should drive the stock price higher, Worthington tells investors in a research note. He maintains an Overweight rating on the shares.
NDAQ Nasdaq
$81.43

-0.13 (-0.16%)

06/22/18
COMP
06/22/18
INITIATION
Target $100
COMP
Neutral
Nasdaq initiated with a Neutral at Compass Point
Compass Point initiated Nasdaq with a Neutral and $100 price target.
06/22/18
WELS
06/22/18
NO CHANGE
Target $104
WELS
Outperform
Nasdaq price target raised to $104 from $95 at Wells Fargo
Wells Fargo analyst Christopher Harris raised his price target for Nasdaq to $104 after hosting investor meetings with management. The analyst left feeling more confident that the company can achieve its higher growth targets, at least over a medium term basis. He suspects the realization of these targets will be good for the stock and reiterates an Outperform rating on Nasdaq.
09/05/18
RSBL
09/05/18
INITIATION
Target $99
RSBL
Neutral
Nasdaq initiated with a Neutral at Rosenblatt
Rosenblatt analyst Ken Hill initiated Nasdaq with a Neutral and $99 price target saying 2018 appears to be a relatively disappointing year from a results perspective, but investments made this year should help elevate future earnings. Hill believes management will be successful on Nasdaq's transformation but recommends investors look for a better entry point.
09/05/18
09/05/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Universal Display (OLED) initiated with a Buy at Citi. 2. Bio-Rad (BIO) initiated with an Equal Weight at Barclays. 3. Amalgamated Bank (AMAL) initiated with an Overweight at Barclays. 4. Pacific City Financial (PCB) initiated with a Buy at Sandler O'Neill. 5. Nasdaq (NDAQ) initiated with a Neutral at Rosenblatt. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
SCHW Charles Schwab
$43.05

0.48 (1.13%)

09/19/18
09/19/18
NO CHANGE

Fly Intel: Today's top analyst calls on Wall Street
Check out today's top analyst calls from around Wall Street, compiled by The Fly. WELLS FARGO UPGRADES TRANSOCEAN TO OUTPERFORM: Wells Fargo analyst Judson Bailey upgraded Transocean (RIG) to Outperform and raised his price target for the shares to $16 from $13. The analyst "significantly" increased his EBITDA and net asset value estimates across the offshore drilling space to reflect increasing demand combined with tightening availability for high spec ultra-deepwater rigs. This is quickly pushing dayrate expectations higher as well as the market value for ultra-deepwater assets, Bailey tells investors. The analyst cites Transocean's deepwater leverage for his upgrade to Outperform. In late morning trading, Transocean was higher by 3.6%. JEFFERIES UPGRADES E-TRADE TO BUY: Jefferies analyst Daniel Fannon upgraded E-Trade (ETFC) to Buy from Hold with an unchanged price target of $65. The stock's current valuation is attractive for the core business while the financial and strategic benefits as a takeout candidate remain intact, Fannon said. His favorite ideas in the group are E-Trade and Charles Schwab (SCHW). In late morning trading, E-Trade was higher by 3.5%. CREDIT SUISSE UPGRADES SUNPOWER: Credit Suisse analyst Michael Weinstein upgraded SunPower (SPWR) to Outperform from Neutral and raised his target price for shares to $10 from $8. Weinstein said the news that its interdigitated back contact solar modules manufactured in Malaysia will be exempted from U.S. import tariffs won't impact 2018 earnings, as the decision doesn't explicitly call out retroactiveness, but sees a benefit to 2019 and 2020 gross profit of $35M-$40M per year vs. prior estimates. In late morning trading, SunPower was higher by 4.7%. MORGAN STANLEY SAYS OIL SERVICES INDUSTRY ATTRACTIVE: Morgan Stanley analyst Connor Lynagh upgraded the oil services, drilling and equipment industry view to attractive, and initiated 14 stocks in the sector, including top Overweight picks Baker Hughes (BHGE), Halliburton (HAL), and Transocean. GUGGENHEIM RAISES NETFLIX PRICE TARGET: Guggenheim analyst Michael Morris raised his price target for Netflix (NFLX) to $420 from $360 and kept a Buy rating on the shares. The analyst believes that Netflix "subscriber penetration will significantly exceed what is implied in the company's current valuation." He thinks the company's Q3 launch of original local-market content in India and upgrades to its user experience will support further upside in the shares.
09/25/18
WOLF
09/25/18
INITIATION
Target $54
WOLF
Underperform
Charles Schwab initiated with an Underperform at Wolfe Research
Wolfe Research analyst Steven Chubak initiated Charles Schwab with an Underperform and $54 price target.
10/16/18
ARGS
10/16/18
NO CHANGE
Target $69
ARGS
Buy
Charles Schwab Q3 saw 'strong balance sheet and account growth' says Argus
Argus analyst Stephen Biggar kept his Buy rating and $69 price target on Charles Schwab after its Q3 results yesterday that saw earnings and revenue come in line with consensus. The analyst notes that the 19% increase in net revenue accelerated from the 17% pace in Q2, adding that client assets also rose 12% while the balance sheet expansion tracked close to meeting the company's 15% growth target for FY18. Biggar believes that shares of Charles Schwab are "undervalued", trading at 16-times forward earnings but warrant a multiple in the mid-20s.
TROW T. Rowe Price
$94.79

1.02 (1.09%)

10/11/18
DBAB
10/11/18
NO CHANGE
DBAB
Sell
Deutsche Bank closes Sell catalyst call on T. Rowe Price
Deutsche Bank analyst Brian Bedell closed his Sell catalyst call on T. Rowe Price and keeps a Hold rating on the shares. Fund flow data from Morningstar, combined with the company's report on transfers to Collective Investment Trusts, imply that T. Rowe Price's net flows may be negative for Q3 for the first time since Q4 of 2016, Bedell tells investors in a research note. He believes, however, that this is better reflected in the shares at current levels.
09/07/18
09/07/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Teva (TEVA) downgraded to Neutral from Outperform at Credit Suisse. 2. Vitamin Shoppe (VSI) downgraded to Underweight from Equal Weight at Barclays with analyst Karen Short raising her price target for the shares to $10 from $4. 3. Dover (DOV) downgraded to Market Perform from Outperform at BMO Capital with analyst R. Scott Graham citing valuation. 4. T. Rowe Price (TROW) downgraded to Hold from Buy at Deutsche Bank with analyst Brian Bedell saying through August, trends are worsening for active managers and T. Rowe Price has posted weaker performance relative to peers. 5. Reliance Steel (RS) double downgraded to Underperform from Buy at BofA/Merrill with analyst Timna Tanners saying he is cautious over late cycle earnings. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/07/18
DBAB
09/07/18
DOWNGRADE
Target $118
DBAB
Hold
Deutsche downgrades T. Rowe Price amid worsening active manager trends
Deutsche Bank analyst Brian Bedell last night downgraded T. Rowe Price to Hold from Buy and lowered his price target for the shares to $118 from $135. Thru August, trends are worsening for active managers and T. Rowe Price has posted weaker performance relative to peers, Bedell tells investors in a research note. In contrast, the analyst sees volumes for e-brokers trending well.
09/06/18
DBAB
09/06/18
DOWNGRADE
Target $118
DBAB
Hold
T. Rowe Price downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Brian Bedell downgraded T. Rowe Price to Hold and lowered his price target for the shares to $118 from $135.
VIRT Virtu Financial
$22.73

0.34 (1.52%)

08/08/18
08/08/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Optinose (OPTN) initiated with an Overweight at Cantor Fitzgerald. 2. BioCryst (BCRX) reinstated with an Overweight at JPMorgan. 3. Dillard's (DDS) initiated with an Outperform at Wedbush. 4. Virtu Financial (VIRT) initiated with an Equal Weight at Morgan Stanley. 5. Assembly Biosciences (ASMB) initiated with an Outperform at Baird. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/19/18
COMP
09/19/18
INITIATION
Target $23
COMP
Neutral
Virtu Financial initiated with a Neutral at Compass Point
Compass Point analyst Chris Allen initiated Virtu Financial with a Neutral and $23 price target saying the challenging operating environment in Q2 has carried over to Q3 and in most asset classes the environment has worsened.
09/19/18
09/19/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Aerpio Pharmaceuticals (ARPO) initiated with a Buy at Guggenheim. 2. Vocera (VCRA) initiated with a Buy at Jefferies. 3. Veoneer (VNE) initiated with a Neutral at Buckingham. 4. Virtu Financial (VIRT) initiated with a Neutral at Compass Point. 5. Internap (INAP) initiated with a Buy at SunTrust. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/05/18
SBSH
10/05/18
NO CHANGE
SBSH
Neutral
Citi views potential ITG deal as favorable for Virtu Financial
A possible acquisition of Investment Technology Group (ITG) by Virtu Financial (VIRT), as reported yesterday by Bloomberg, points to "solid upside," Citi analyst Ben Herbert tell investors in a research note. The analyst views the potential deal favorably for Virtu given his belief that the company's standalone earnings growth may remain challenged against the current environment. His initial pass at potential deal accretion indicates $3.50 per share of upside for Virtu. Herbert keeps a Hold rating on Virtu shares.

TODAY'S FREE FLY STORIES

NVCN

Neovasc

$0.48

-0.0023 (-0.48%)

17:36
05/22/19
05/22
17:36
05/22/19
17:36
Hot Stocks
Neovasc discloses International Journal of Cardiology review of Neovasc Reducer »

Neovasc announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$285.61

-0.89 (-0.31%)

17:36
05/22/19
05/22
17:36
05/22/19
17:36
Periodicals
Pentagon mulls request to send 5,000 U.S. troops to Middle East, Reuters says »

The U.S. Department of…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$285.61

-0.89 (-0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

POOL

Pool Corp.

$183.36

-0.52 (-0.28%)

17:35
05/22/19
05/22
17:35
05/22/19
17:35
Hot Stocks
Pool Corp. Chairman John Stokely sells almost $2M in company shares »

Pool Corp. Chairman John…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 18

    Jun

  • 13

    Nov

RTN

Raytheon

$180.57

-2.05 (-1.12%)

17:35
05/22/19
05/22
17:35
05/22/19
17:35
Hot Stocks
Raytheon awarded $151.47M Navy contract for AIM-9X missile sustainment »

Raytheon has been awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 05

    Jun

ESV

Ensco Rowan

$10.01

-0.365 (-3.52%)

17:31
05/22/19
05/22
17:31
05/22/19
17:31
Hot Stocks
Ensco Rowan says will not pay a regular quarterly cash dividend »

Ensco Rowan announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$171.29

1.67 (0.98%)

, GILD

Gilead

$66.51

-0.01 (-0.02%)

17:30
05/22/19
05/22
17:30
05/22/19
17:30
Upgrade
Amgen, Gilead, Alexion, Vertex, BioMarin, Biogen, Regeneron rating change  »

Citi assumes coverage of…

AMGN

Amgen

$171.29

1.67 (0.98%)

GILD

Gilead

$66.51

-0.01 (-0.02%)

ALXN

Alexion

$127.47

-1.33 (-1.03%)

VRTX

Vertex

$172.37

3.22 (1.90%)

BMRN

BioMarin

$87.80

0.33 (0.38%)

BIIB

Biogen

$234.98

2.04 (0.88%)

REGN

Regeneron

$320.00

10.19 (3.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 31

    May

  • 04

    Jun

  • 05

    Jun

  • 05

    Jun

  • 13

    Jun

  • 14

    Jun

  • 26

    Jun

  • 28

    Jun

BBX

BBX Capital

$4.95

-0.06 (-1.20%)

, BXG

Bluegreen Vacations

$14.91

-0.2 (-1.32%)

17:24
05/22/19
05/22
17:24
05/22/19
17:24
Hot Stocks
BBX Capital says will not proceed with merger with Bluegreen Vacations »

BBX Capital (BBX)…

BBX

BBX Capital

$4.95

-0.06 (-1.20%)

BXG

Bluegreen Vacations

$14.91

-0.2 (-1.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

  • 19

    Jun

RTN

Raytheon

$180.57

-2.05 (-1.12%)

17:21
05/22/19
05/22
17:21
05/22/19
17:21
Hot Stocks
Raytheon awarded $234.64M Navy contract »

Raytheon has been awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 05

    Jun

WEX

Wex

$203.30

-1.56 (-0.76%)

17:20
05/22/19
05/22
17:20
05/22/19
17:20
Hot Stocks
Wex CEO sells 5K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 05

    Jun

RTLR

Rattler Midstream

$0.00

(0.00%)

17:19
05/22/19
05/22
17:19
05/22/19
17:19
Syndicate
Rattler Midstream 38M share IPO priced at $17.50 »

The IPO was upsized to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

GILD

Gilead

$66.51

-0.01 (-0.02%)

17:19
05/22/19
05/22
17:19
05/22/19
17:19
Upgrade
Gilead rating change  »

Gilead upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

SERV

ServiceMaster

$54.18

-0.1 (-0.18%)

17:18
05/22/19
05/22
17:18
05/22/19
17:18
Hot Stocks
ServiceMaster director sells 8.5K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 18

    Jun

AMGN

Amgen

$171.29

1.67 (0.98%)

17:18
05/22/19
05/22
17:18
05/22/19
17:18
Upgrade
Amgen rating change  »

Amgen upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

SBLK

Star Bulk Carriers

$8.13

-0.13 (-1.57%)

17:17
05/22/19
05/22
17:17
05/22/19
17:17
Earnings
Star Bulk Carriers reports Q1 EPS (9c), consensus (4c) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

IBM

IBM

$136.34

-0.12 (-0.09%)

17:14
05/22/19
05/22
17:14
05/22/19
17:14
Hot Stocks
IBM awarded $275M DMEA contract »

IBM has been awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

AVP

Avon Products

$3.49

0.295 (9.23%)

17:09
05/22/19
05/22
17:09
05/22/19
17:09
Hot Stocks
Avon Products jumps another 16% after Natura confirms deal »

Shares of Avon are up 56c…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSBC

HSBC

$41.72

0.02 (0.05%)

17:05
05/22/19
05/22
17:05
05/22/19
17:05
Upgrade
HSBC rating change  »

HSBC upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

AVP

Avon Products

$3.49

0.295 (9.23%)

17:04
05/22/19
05/22
17:04
05/22/19
17:04
Hot Stocks
Natura confirms Avon Products deal with combined group's enterprise value $11B »

Natura &Co announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SITE

SiteOne Landscape

$64.36

-2.095 (-3.15%)

17:02
05/22/19
05/22
17:02
05/22/19
17:02
Hot Stocks
SiteOne Landscape acquires Stone and Soil Depot in San Antonio »

SiteOne Landscape…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 05

    Jun

RJF

Raymond James

$85.16

-0.64 (-0.75%)

16:53
05/22/19
05/22
16:53
05/22/19
16:53
Hot Stocks
Breaking Hot Stocks news story on Raymond James »

Raymond James reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTAP

NetApp

$67.08

-2.93 (-4.19%)

16:45
05/22/19
05/22
16:45
05/22/19
16:45
Hot Stocks
Breaking Hot Stocks news story on NetApp »

NetApp down 6% after Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 06

    Jun

  • 09

    Jul

YNDX

Yandex

$37.67

0.255 (0.68%)

16:43
05/22/19
05/22
16:43
05/22/19
16:43
Hot Stocks
Yandex appoints Tigran Khudaverdyan Deputy CEO »

Yandex announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRTA

Prothena

$9.21

-0.31 (-3.26%)

16:39
05/22/19
05/22
16:39
05/22/19
16:39
Syndicate
Breaking Syndicate news story on Prothena »

Prothena files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LQDA

Liquidia Technologies

$10.34

0.28 (2.78%)

16:39
05/22/19
05/22
16:39
05/22/19
16:39
Hot Stocks
Liquidia Technologies appoints Richard Katz CFO »

Liquidia Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WHR

Whirlpool

$131.06

-1.5 (-1.13%)

16:36
05/22/19
05/22
16:36
05/22/19
16:36
Hot Stocks
Whirlpool reaffirms 2019 guidance, looks for ROIC of 12-14% in long-term »

Whirlpool is meeting with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.